← Back to Search

Parasternal blocks for Coronary Artery Bypass Surgery

Phase 3
Waitlist Available
Research Sponsored by Jewish General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately as intervention is performed
Awards & highlights

Study Summary

This trial will test how well parasternal blocks with local anesthetic drugs work to relieve pain after CABG surgery.

Who is the study for?
This trial is for patients scheduled for elective or urgent coronary artery bypass surgery who can give consent. It's not suitable for those with regular opioid use or chronic pain history.Check my eligibility
What is being tested?
The study tests the effectiveness of parasternal blocks, a type of regional anesthesia, in managing post-surgery pain compared to standard care after coronary artery bypass grafting.See study design
What are the potential side effects?
Parasternal blocks may cause side effects like localized discomfort, potential nerve damage, infection at the injection site, and inadequate pain relief requiring additional analgesics.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from icu arrival until first ambulation (approximately first 72 hours postoperatively)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from icu arrival until first ambulation (approximately first 72 hours postoperatively) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain with inspirometry at 24 hours after surgery
Secondary outcome measures
Ambulation
Amount of rescue analgesia administered
Hospital Length of Stay
+7 more
Other outcome measures
Incidence of a pneumothorax
Incidence of bradycardia
Incidence of hyperglycemia
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention groupExperimental Treatment1 Intervention
Patients will receive bilateral parasternal blocks at the end of cardiac surgery.
Group II: Control groupPlacebo Group1 Intervention
Patients will receive all standard care as per the hospital protocols.

Find a Location

Who is running the clinical trial?

Jewish General HospitalLead Sponsor
138 Previous Clinical Trials
272,334 Total Patients Enrolled

Media Library

Parasternal blocks Clinical Trial Eligibility Overview. Trial Name: NCT05191745 — Phase 3
Coronary Artery Bypass Surgery Research Study Groups: Intervention group, Control group
Coronary Artery Bypass Surgery Clinical Trial 2023: Parasternal blocks Highlights & Side Effects. Trial Name: NCT05191745 — Phase 3
Parasternal blocks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05191745 — Phase 3
~18 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top